Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  JURIKA WILLIAM K
 2. Date of Event Requiring Statement (Month/Day/Year)
04/29/2009		 3. Issuer Name and Ticker or Trading Symbol
QUADRAMED CORP [QDHC]
(Last)
(First)
(Middle)
C/O QUADRAMED CORPORATION, 12110 SUNSET HILLS ROAD, SUITE 600		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
04/29/2009
(Street)

RESTON, VA 20190		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 53,600
D (1)
 
Common Stock 603,104
I
By the Jurika Family Trust, U/A 1989
Common Stock 3,740
I
By the Michelle Jurika, IRA
Common Stock 0 (2)
I
By Counterpoint Fund, L.P. (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
JURIKA WILLIAM K
C/O QUADRAMED CORPORATION
12110 SUNSET HILLS ROAD, SUITE 600
RESTON, VA 20190		   X      

Signatures

/s/ Kelly G. Howard as Attorney in Fact for William K. Jurika 12/18/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) By the William K. Jurika IRA
(2) The Counterpoint Fund, L.P. sold its QuadraMed shares in the following transactions, all prior to Mr. Jurika joining the Board of Directors: 2/24/2009: 3,277 common shares sold at a price of $5.985; 2/25/2009: 6,400 common shares sold at a price of $5.979; 2/26/2009 11,100 common shares sold at a price of $5.981; 2/28/2009 15,000 common shares sold at a price of $5.994.
(3) The Jurika Family Trust, U/A 1989 owns 48.1% of Counterpoint Fund L.P., which is managed by Jurika, Mills, & Keifer, LLC ("JMK"), with Mr. Jurika acting as the managing member of JMK.
 
Remarks:
Explanatory Note:  This Amended Form 3 is being filed to amend and restate the original Form 3 as filed with the SEC on May 1, 2009 which reported a holding of 35,777 shares by Counterpoint Fund, L.P.  As set forth in Footnote 2 above, Counterpoint Fund, L.P. sold its position in QuadraMed prior to Mr. Jurika joining the Board of Directors of QuadraMed Corporation on April 29, 2009.  No indirectly owned shares by the Counterpoint Fund, L.P. should have been reported on Mr. Jurika's original Form 3.  No other amendments to the original Form 3 have been made.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.